Press Releases on January 9, 2020 - EIN Presswire - Press Release Distribution Service

Published on January 9, 2020 - 13:00 GMT

Todos Medical Enters into Exclusive Option Agreement to Acquire Provista Diagnostics and Announces Management Changes

REHOVOT, Israel, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, today announced …

Distribution channels: Companies, Technology ...

Published on January 9, 2020 - 13:00 GMT

Nurix Therapeutics and Sanofi Establish Strategic Collaboration to Develop Novel Targeted Protein Degradation Therapies

SAN FRANCISCO, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company researching novel therapies that control degradation of disease-causing proteins, today announced a global strategic collaboration with Sanofi to discover, develop and …

Distribution channels: Media, Advertising & PR ...

Published on January 9, 2020 - 13:00 GMT

Foamix Announces AMZEEQ™ (minocycline) Topical Foam Available in Pharmacies Nationwide on January 13th for the Treatment of ...

AMZEEQ is the First FDA Approved Topical Form of Minocycline and the Company’s First Commercial Launch AMZEEQ Offers Efficacy with Low Systemic Absorption List price of $485 Competitive Against Current Acne Market Leaders REHOVOT, Israel and BRIDGEWATER, N …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 9, 2020 - 13:00 GMT

Cellectar Biosciences to Host a CLR 131 Clinical Data Call with Its Phase 2 Lead Investigator on February 19, 2020

FLORHAM PARK, N.J., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced …

Distribution channels: Culture, Society & Lifestyle

Published on January 9, 2020 - 13:00 GMT

IntelGenx Enters Animal Health Market by Signing Feasibility Agreement for VetaFilm™ Platform

SAINT LAURENT, Quebec, Jan. 09, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”) a leader in pharmaceutical films, today announced that it has entered into a Feasibility Study Agreement (the “Agreement”) with an undisclosed …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 9, 2020 - 13:00 GMT

270Surgical Ltd. Announces CE Mark Clearance of its SurroundScope System, which Offers an Extended Field-of-View

USPTO Issues Key Patents for the SurroundScope System U.S. commercial launch of the SurroundScope System is on track for the second half of 2020 NETANYA, Israel and DALLAS, Jan. 09, 2020 (GLOBE NEWSWIRE) -- 270Surgical Ltd. (the “Company”) today announced …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 9, 2020 - 13:00 GMT

LifeVantage Posts Record Second Quarter Preliminary Revenue, Introduces Free Shipping in 2020

Preliminary revenue of approximately $61 million represents the highest quarterly revenue in company history LifeVantage to ring the Nasdaq closing bell today in celebration of “Wellness Week” LifeVantage to present at the 22nd Annual ICR Conference on …

Distribution channels:

Published on January 9, 2020 - 13:00 GMT

Kaleido Biosciences Announces Collaboration with Janssen to Explore the Potential for Microbiome Metabolic Therapies (MMT™) to ...

LEXINGTON, Mass., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and improve human health, today announced …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 9, 2020 - 13:00 GMT

Precision Nutrition Opening a Limited Number of New Registration Spots for its Personal Coaching Program to Help Individuals Get ...

TORONTO, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Precision Nutrition, an industry leader in healthy eating and lifestyle coaching, is opening a limited number of registration spots on January 15, 2020 for its Precision Nutrition Coaching. As part of the 12-month …

Distribution channels: Culture, Society & Lifestyle, Food & Beverage Industry ...

Published on January 9, 2020 - 13:00 GMT

Kintai Therapeutics Appoints Biotech Veteran John Mendlein, Ph.D., as Chairman of the Board of Directors

CAMBRIDGE, Mass., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company, today announced the appointment of biotech industry veteran John Mendlein, Ph.D., to its Board of Directors as chairman of the board. Dr. Mendlein, who …

Distribution channels: Companies, Technology ...

Published on January 9, 2020 - 13:00 GMT

SI-BONE Reports Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2019 and Provides Full Year 2020 Revenue Guidance

SANTA CLARA, Calif., Jan. 09, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced preliminary unaudited revenue for the fourth quarter …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on January 9, 2020 - 13:00 GMT

Envision Announces Issuance of us Patent for Curbside Electric Vehicle Charging Infrastructure Product

SAN DIEGO, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Envision Solar International, Inc., (Nasdaq: EVSI, EVSIW) (“Envision Solar,” or the “Company”), the leading producer of unique and sustainable infrastructure products for electric vehicle charging, energy …

Distribution channels:

Published on January 9, 2020 - 13:00 GMT

Nkarta Therapeutics to Present at the J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Nkarta Therapeutics, a privately-held biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, announced today that the company’s chief executive …

Distribution channels: Conferences & Trade Fairs, Culture, Society & Lifestyle ...

Published on January 9, 2020 - 13:00 GMT

La Jolla Pharmaceutical Company Announces Preliminary GIAPREZA™ (Angiotensin II) Net Sales for the Three and Twelve Months Ended ...

SAN DIEGO, Jan. 09, 2020 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life- …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 9, 2020 - 13:00 GMT

Soul Machines Raises US$40M Series B From Global Investment Community to Advance the Way Humans and Machines Collaborate

AUCKLAND, New Zealand, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Soul Machines, the ground-breaking company re-imagining how humans connect with machines, today announced its US$40 million series B financing. Soul Machines is an AGI Research company developing the …

Distribution channels: Media, Advertising & PR

Published on January 9, 2020 - 13:00 GMT

Immutep Expands Part C of TACTI-002 Due to Positive Data

Recruitment completed for stage 1 of Part C of TACTI-002 trial, for patients with second line Head and Neck Squamous Cell Carcinoma (HNSCC) Part C has been expanded to include an additional 19 HNSCC patients, creating stage 2 of Part C Follows Data …

Distribution channels: Media, Advertising & PR, Technology ...

Published on January 9, 2020 - 13:00 GMT

Pender Growth Fund Announces the Acquisition of one of its Portfolio Companies

VANCOUVER, British Columbia, Jan. 09, 2020 (GLOBE NEWSWIRE) -- (TSXV: PTF) Pender Growth Fund Inc. (the “Company”) is pleased to announce the closing of the previously announced acquisition of BasicGov Systems, Inc. (“BasicGov”), one of the Company’s …

Distribution channels: Banking, Finance & Investment Industry, Media, Advertising & PR

Published on January 9, 2020 - 13:00 GMT

CN and NorFalco Sign Agreement

MONTREAL, Jan. 09, 2020 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) and NorFalco Sales, a division of Glencore Canada Corporation, announced they have signed a new multi-year agreement that will provide freight transportation of Sulphuric Acid from …

Distribution channels: Companies, Media, Advertising & PR ...

Published on January 9, 2020 - 13:00 GMT

REPEAT - AgraFlora Organics’ Exclusive CBD Sports Partner to Advertise Performance Products on 2020 RLF Super League Jersey

VANCOUVER, British Columbia, Jan. 09, 2020 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 9, 2020 - 13:00 GMT

Oxford BioTherapeutics Initiates Dose-Escalation Portion of U.S. Phase I Clinical Trial for OBT076 in Patients with Advanced Solid ...

Dose-escalation starting at a dose based on results from a European study sponsored by partner, Menarini Ricerche. Phase I program includes two U.S. expansion cohorts: (1) High risk cohort of HER2 negative, Hormone receptor positive (HER2-/HR+) …

Distribution channels: Healthcare & Pharmaceuticals Industry